Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation

Katalin Völgyi, Krisztina Háden, Viktor Kis, Péter Gulyássy, Kata Badics, B. Györffy, Attila Simor, Zoltán Szabó, T. Janáky, L. Drahos, A. Dobolyi, B. Penke, G. Juhász, K. Kékesi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is a multifactorial disease of wide clinical heterogenity. Overproduction of amyloid precursor protein (APP) and accumulation of β-amyloid (Aβ) and tau proteins are important hallmarks of AD. The identification of early pathomechanisms of AD is critically important for discovery of early diagnosis markers. Decreased brain metabolism is one of the earliest clinical symptoms of AD that indicate mitochondrial dysfunction in the brain. We performed the first comprehensive study integrating synaptic and non-synaptic mitochondrial proteome analysis (two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry) in correlation with Aβ progression in APP/PS1 mice (3, 6, and 9 months of age). We identified changes of 60 mitochondrial proteins that reflect the progressive effect of APP overproduction and Aβ accumulation on mitochondrial processes. Most of the significantly affected proteins play role in the mitochondrial electron transport chain, citric acid cycle, oxidative stress, or apoptosis. Altered expression levels of Htra2 and Ethe1, which showed parallel changes in different age groups, were confirmed also by Western blot. The common regulator bioinformatical analysis suggests the regulatory role of tumor necrosis factor (TNF) in Aβ-mediated mitochondrial protein changes. Our results are in accordance with the previous postmortem human brain proteomic studies in AD in the case of many proteins. Our results could open a new path of research aiming early mitochondrial molecular mechanisms of Aβ accumulation as a prodromal stage of human AD.

Original languageEnglish
Pages (from-to)1-19
Number of pages19
JournalMolecular Neurobiology
DOIs
Publication statusAccepted/In press - Feb 24 2016

Fingerprint

Proteome
Amyloid
Alzheimer Disease
Amyloid beta-Protein Precursor
Serum Amyloid A Protein
Mitochondrial Proteins
Brain
Two-Dimensional Difference Gel Electrophoresis
Prodromal Symptoms
tau Proteins
Citric Acid Cycle
Electrophoresis, Gel, Two-Dimensional
Electron Transport
Proteomics
Early Diagnosis
Mass Spectrometry
Proteins
Oxidative Stress
Age Groups
Tumor Necrosis Factor-alpha

Keywords

  • Alzheimer’s disease (AD)
  • APP/PS1 mouse model
  • Non-synaptic mitochondria
  • Synaptic mitochondria
  • β-Amyloid (Aβ)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation. / Völgyi, Katalin; Háden, Krisztina; Kis, Viktor; Gulyássy, Péter; Badics, Kata; Györffy, B.; Simor, Attila; Szabó, Zoltán; Janáky, T.; Drahos, L.; Dobolyi, A.; Penke, B.; Juhász, G.; Kékesi, K.

In: Molecular Neurobiology, 24.02.2016, p. 1-19.

Research output: Contribution to journalArticle

Völgyi, Katalin ; Háden, Krisztina ; Kis, Viktor ; Gulyássy, Péter ; Badics, Kata ; Györffy, B. ; Simor, Attila ; Szabó, Zoltán ; Janáky, T. ; Drahos, L. ; Dobolyi, A. ; Penke, B. ; Juhász, G. ; Kékesi, K. / Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation. In: Molecular Neurobiology. 2016 ; pp. 1-19.
@article{d2d97c206d0d4bc1bfb1857b958fe848,
title = "Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation",
abstract = "Alzheimer’s disease (AD) is a multifactorial disease of wide clinical heterogenity. Overproduction of amyloid precursor protein (APP) and accumulation of β-amyloid (Aβ) and tau proteins are important hallmarks of AD. The identification of early pathomechanisms of AD is critically important for discovery of early diagnosis markers. Decreased brain metabolism is one of the earliest clinical symptoms of AD that indicate mitochondrial dysfunction in the brain. We performed the first comprehensive study integrating synaptic and non-synaptic mitochondrial proteome analysis (two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry) in correlation with Aβ progression in APP/PS1 mice (3, 6, and 9 months of age). We identified changes of 60 mitochondrial proteins that reflect the progressive effect of APP overproduction and Aβ accumulation on mitochondrial processes. Most of the significantly affected proteins play role in the mitochondrial electron transport chain, citric acid cycle, oxidative stress, or apoptosis. Altered expression levels of Htra2 and Ethe1, which showed parallel changes in different age groups, were confirmed also by Western blot. The common regulator bioinformatical analysis suggests the regulatory role of tumor necrosis factor (TNF) in Aβ-mediated mitochondrial protein changes. Our results are in accordance with the previous postmortem human brain proteomic studies in AD in the case of many proteins. Our results could open a new path of research aiming early mitochondrial molecular mechanisms of Aβ accumulation as a prodromal stage of human AD.",
keywords = "Alzheimer’s disease (AD), APP/PS1 mouse model, Non-synaptic mitochondria, Synaptic mitochondria, β-Amyloid (Aβ)",
author = "Katalin V{\"o}lgyi and Krisztina H{\'a}den and Viktor Kis and P{\'e}ter Guly{\'a}ssy and Kata Badics and B. Gy{\"o}rffy and Attila Simor and Zolt{\'a}n Szab{\'o} and T. Jan{\'a}ky and L. Drahos and A. Dobolyi and B. Penke and G. Juh{\'a}sz and K. K{\'e}kesi",
year = "2016",
month = "2",
day = "24",
doi = "10.1007/s12035-015-9682-4",
language = "English",
pages = "1--19",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",

}

TY - JOUR

T1 - Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation

AU - Völgyi, Katalin

AU - Háden, Krisztina

AU - Kis, Viktor

AU - Gulyássy, Péter

AU - Badics, Kata

AU - Györffy, B.

AU - Simor, Attila

AU - Szabó, Zoltán

AU - Janáky, T.

AU - Drahos, L.

AU - Dobolyi, A.

AU - Penke, B.

AU - Juhász, G.

AU - Kékesi, K.

PY - 2016/2/24

Y1 - 2016/2/24

N2 - Alzheimer’s disease (AD) is a multifactorial disease of wide clinical heterogenity. Overproduction of amyloid precursor protein (APP) and accumulation of β-amyloid (Aβ) and tau proteins are important hallmarks of AD. The identification of early pathomechanisms of AD is critically important for discovery of early diagnosis markers. Decreased brain metabolism is one of the earliest clinical symptoms of AD that indicate mitochondrial dysfunction in the brain. We performed the first comprehensive study integrating synaptic and non-synaptic mitochondrial proteome analysis (two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry) in correlation with Aβ progression in APP/PS1 mice (3, 6, and 9 months of age). We identified changes of 60 mitochondrial proteins that reflect the progressive effect of APP overproduction and Aβ accumulation on mitochondrial processes. Most of the significantly affected proteins play role in the mitochondrial electron transport chain, citric acid cycle, oxidative stress, or apoptosis. Altered expression levels of Htra2 and Ethe1, which showed parallel changes in different age groups, were confirmed also by Western blot. The common regulator bioinformatical analysis suggests the regulatory role of tumor necrosis factor (TNF) in Aβ-mediated mitochondrial protein changes. Our results are in accordance with the previous postmortem human brain proteomic studies in AD in the case of many proteins. Our results could open a new path of research aiming early mitochondrial molecular mechanisms of Aβ accumulation as a prodromal stage of human AD.

AB - Alzheimer’s disease (AD) is a multifactorial disease of wide clinical heterogenity. Overproduction of amyloid precursor protein (APP) and accumulation of β-amyloid (Aβ) and tau proteins are important hallmarks of AD. The identification of early pathomechanisms of AD is critically important for discovery of early diagnosis markers. Decreased brain metabolism is one of the earliest clinical symptoms of AD that indicate mitochondrial dysfunction in the brain. We performed the first comprehensive study integrating synaptic and non-synaptic mitochondrial proteome analysis (two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry) in correlation with Aβ progression in APP/PS1 mice (3, 6, and 9 months of age). We identified changes of 60 mitochondrial proteins that reflect the progressive effect of APP overproduction and Aβ accumulation on mitochondrial processes. Most of the significantly affected proteins play role in the mitochondrial electron transport chain, citric acid cycle, oxidative stress, or apoptosis. Altered expression levels of Htra2 and Ethe1, which showed parallel changes in different age groups, were confirmed also by Western blot. The common regulator bioinformatical analysis suggests the regulatory role of tumor necrosis factor (TNF) in Aβ-mediated mitochondrial protein changes. Our results are in accordance with the previous postmortem human brain proteomic studies in AD in the case of many proteins. Our results could open a new path of research aiming early mitochondrial molecular mechanisms of Aβ accumulation as a prodromal stage of human AD.

KW - Alzheimer’s disease (AD)

KW - APP/PS1 mouse model

KW - Non-synaptic mitochondria

KW - Synaptic mitochondria

KW - β-Amyloid (Aβ)

UR - http://www.scopus.com/inward/record.url?scp=84959110727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959110727&partnerID=8YFLogxK

U2 - 10.1007/s12035-015-9682-4

DO - 10.1007/s12035-015-9682-4

M3 - Article

C2 - 26910821

AN - SCOPUS:84959110727

SP - 1

EP - 19

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

ER -